Yuanzhuo Wang

Yuanzhuo Wang

Auto-generated profile, based on publicly available information

Yuanzhuo Wang

Department of Dermatology Peking Union Medical College Hospital Beijing China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2020 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
KTKeyun Tang
Keyun Tang
YWYuanzhuo Wang
Yuanzhuo Wang
HZHanlin Zhang
Hanlin Zhang
QZQingyue Zheng
Qingyue Zheng
RFRouyu Fang
Rouyu Fang
QSQiuning Sun
Qiuning Sun

20 February 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
YWYuanzhuo Wang
Yuanzhuo Wang
HZHanlin Zhang
Hanlin Zhang
RFRouyu Fang
Rouyu Fang
KTKeyun Tang
Keyun Tang
QSQiuning Sun
Qiuning Sun

1 April 2021 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
HZHanlin Zhang
Hanlin Zhang
KTKeyun Tang
Keyun Tang
YWYuanzhuo Wang
Yuanzhuo Wang
RFRouyu Fang
Rouyu Fang
QSQiuning Sun
Qiuning Sun
Background: Rosacea is a chronic skin disorder characterized by erythema, flushing, telangiectasia, papules and pustules, phymatous changes, and ocular involvement. The aim of this study was to examine all published research articles in which botulinum toxin was used to treat rosacea and to evaluate the efficacy and safety of this treatment. Methods: PubMed, Embase, Cochrane Library, and Web of Science database were used to identify articles eligible for systematic review on March 26, 2021. Prospective or retrospective studies which directly used botulinum toxin to treat rosacea were included and reviewed. Results: Nine studies were included in this systematic review. Two were randomized controlled trials, graded as Level 2 for the quality of evidence. The total number of participants was 130, and the number of participants in each study ranged from 1 to 25. The improvement was observed in all studies in signs and symptoms compared with baseline. Adverse events were transitory and self-limited. Conclusion: Botulinum toxin could have overall satisfying efficacy and safety in the treatment of rosacea, though limited by small sample size, imperfect study design, and short follow-up visits.

3 August 2020 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
YWYuanzhuo Wang
Yuanzhuo Wang
HZHanlin Zhang
Hanlin Zhang
QZQingyue Zheng
Qingyue Zheng
KTKeyun Tang
Keyun Tang
RFRouyu Fang
Rouyu Fang
QSQiuning Sun
Qiuning Sun

2 July 2020 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
YWYuanzhuo Wang
Yuanzhuo Wang
RFRouyu Fang
Rouyu Fang
HZHanlin Zhang
Hanlin Zhang
KTKeyun Tang
Keyun Tang
QSQiuning Sun
Qiuning Sun

16 July 2020 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
YWYuanzhuo Wang
Yuanzhuo Wang
HZHanlin Zhang
Hanlin Zhang
QZQingyue Zheng
Qingyue Zheng
KTKeyun Tang
Keyun Tang
QSQiuning Sun
Qiuning Sun